Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Altmann

Showing results (301-310 of 383) with videos related to

Pageof 39
Sort By:
Arthritis Research & Therapy|May 18, 2006
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic miceAlexei von Delwig, Catharien M U Hilkens, Daniel M Altmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2009
A role of cellular prion protein in programming T-cell cytokine responses in diseaseRebecca J Ingram, Jeremy D Isaacs, Gurman Kaur, et al.
Neurourology and Urodynamics|November 14, 2014
Influence of animal husbandry practices on void spot assay outcomes in C57BL/6J male miceKimberly P Keil, Lisa L Abler, Helene M Altmann, et al.
Nature Communications|March 6, 2024
Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosisMikias Negash, Menberework Chanyalew, Tigist Girma, et al.
Journal of Neuroinflammation|January 4, 2012
Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)Pascal F Durrenberger, Anna Ettorre, Fatemah Kamel, et al.
Immunology|June 4, 2014
The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II allelesCatherine J Reynolds, Claire Jones, Christoph J Blohmke, et al.
Bulletin of the World Health Organization|January 1, 1973
BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in BurmaL M Bechelli, P G Garbajosa, M M Gyi, et al.
International Immunology|January 14, 1999
Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic miceR J Boyton, T Lohmann, M Londei, et al.
Clinical and Experimental Immunology|April 24, 2013
Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1R J Ingram, A Harris, S Ascough, et al.
Plos Computational Biology|March 9, 2016
BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot DataLies Boelen, Patrick K O'Neill, Kathryn J Quigley, et al.
Pageof 39

Showing results (301-310 of 383) with videos related to

Sort By:
Pageof 39
Arthritis Research & Therapy|May 18, 2006
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic miceAlexei von Delwig, Catharien M U Hilkens, Daniel M Altmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2009
A role of cellular prion protein in programming T-cell cytokine responses in diseaseRebecca J Ingram, Jeremy D Isaacs, Gurman Kaur, et al.
Neurourology and Urodynamics|November 14, 2014
Influence of animal husbandry practices on void spot assay outcomes in C57BL/6J male miceKimberly P Keil, Lisa L Abler, Helene M Altmann, et al.
Nature Communications|March 6, 2024
Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosisMikias Negash, Menberework Chanyalew, Tigist Girma, et al.
Journal of Neuroinflammation|January 4, 2012
Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)Pascal F Durrenberger, Anna Ettorre, Fatemah Kamel, et al.
Immunology|June 4, 2014
The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II allelesCatherine J Reynolds, Claire Jones, Christoph J Blohmke, et al.
Bulletin of the World Health Organization|January 1, 1973
BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in BurmaL M Bechelli, P G Garbajosa, M M Gyi, et al.
International Immunology|January 14, 1999
Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic miceR J Boyton, T Lohmann, M Londei, et al.
Clinical and Experimental Immunology|April 24, 2013
Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1R J Ingram, A Harris, S Ascough, et al.
Plos Computational Biology|March 9, 2016
BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot DataLies Boelen, Patrick K O'Neill, Kathryn J Quigley, et al.
Pageof 39